# Quantitative Prostate Cancer Contrast-enhanced Ultrasound

> **NCT02295449** · NA · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 130 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** biopsy sample performed after the SonoVue® injection

## Key facts

- **NCT ID:** NCT02295449
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06-09
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02295449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02295449, "Quantitative Prostate Cancer Contrast-enhanced Ultrasound". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02295449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*